IFNα-2a protects mice against a helminth infection of the liver and modulates immune responses

Gastroenterology

Volumn 124, Issue 5, 2003, Pages 1441-1450

  Godot, Véronique ^a   Harraga, Saïd ^a   Podoprigora, Guennady ^b   Liance, Martine ^c   Bardonnet, Karine ^a   Vuitton, Dominique A ^a,d  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b Interregional Institute of Cytochemistry   (Russian Federation)

^c FACULTÉ DE MÉDECINE   (France)

^d Faculté de Médecine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LAROFERON; RECOMBINANT ALPHA2A INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHINOCOCCUS MULTILOCULARIS; FEMALE; HELMINTHIASIS; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; LIVER HYDATID CYST; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

EID: 0038297448     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00273-7     Document Type: Article

References (47)

1. Bresson-Hadni S, Vuitton DA, Bartholomot B, Heyd B, Godart D, Meyer JP, Hrusovsky S, Becker MC, Mantion G, Lenys D, Miguet JP. A twenty-year history of alveolar echinococcosis: analysis of a series of 117 patients from eastern France. Eur J Gastroenterol Hepatol 2000;12:327-336.
2. Schantz PM, Chai J, Craig PS, Eckert J, Jenkins DJ, Macpherson CNL, Thakur A. Epidemiology and control of hydatid disease, In: Thompson RCA, Lymbery AJ, ed. Echinococcus and hydatid disease. Wallingford, England: Cab International, 1995:233-331.
3. Bresson-Hadni S, Beurton I, Bartholomot B, Vuitton DA, Kern P, Mantion G, Miguet JP. Alveolar echinococcosis. Hepatology 1998;27:1453-1456.
4. World Health Organization-Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bull WHO 1996;74:231-242.
5. Harraga S, Godot V, Bresson-Hadni S, Pater C, Beurton I, Bartholomot B, Vuitton DA. Clinical efficacy and switch from Th2 to Th1 cytokine profile after interferon-α2a monotherapy in human echinococcosis. Clin Infect Dis 1999;29:205-206.
6. Vuitton DA, Bresson-Hadni S, Laroche L, Kaiserlian D, Guerret-Stocker S, Bresson JL, Gillet M. Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Clin Exp Immunol 1989;78:67-74.
7. Emery I, Liance M, Demiaud E, Vuitton DA, Houin R, Leclerc C. Characterization of T-cell immune responses of Echinococcus multilocularis-infected C57BL/6J mice. Parasite Immunol 1996;18:1-10.
8. Bresson-Hadni S, Koch S, Beurton I, Vuitton DA, Bartholomot B, Hrusovski S, Heyd B, Lenys D, Minello A, Becker MC, Vanlemmens C, Mantion G, Miguet JP. Primary disease recurrence after liver transplantation for alveolar echinococcosis: long term evaluation in 15 patients. Hepatology 1999;30:857-864.
9. Sailer M, Soelder B, Allerberger F, Zaknun D, Feichtinger H, Gottstein B. Alveolar echinococcosis of the liver in a six-year-old girl with acquired immunodeficiency syndrome. J Pediatr 1997;130:320-323.
10. Ricard-Blum S, Bresson-Hadni S, Vuitton DA, Ville G, Grimaud JA. Hydroxypyridinum collagen cross-links in human liver fibrosis: study of alveolar echinococcosis. Hepatology 1992;15:599-602.
11. Ricard-Blum S, Bresson-Hadni S, Guerret S, Grenard P, Volle PJ, Risteli L, Grimaud JA, Vuitton DA. Mechanism of collagen network stabilization in human irreversible granulomatous liver fibrosis. Gastroenterology 1996;111:172-182.
12. Godot V, Harraga S, Deschaseaux M, Bresson-Hadni S, Gottstein B, Emilie D, Vuitton DA. Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis. Eur Cytokine Netw 1997;8:401-408.
13. Godot V, Harraga S, Beurton I, Deschaseaux M, Sarciron M, Gottstein B, Vuitton DA. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions. Clin Exp Immunol 2000;121:484-490.
14. Eiermann TH, Bettens F, Tiberghien P, Schmitz K, Beurton I, Bresson-Hadni S, Ammann RW, Goldmann SF, Vuitton DA, Gottstein B, Kern P. HLA and alveolar echinococcosis. Tissue Antigens 1998;52:124-129.
15. Godot V, Harraga S, Beurton I, Deschaseaux M, Sarciron M, Gottstein B, Vuitton DA. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype. Clin Exp Immunol 2000;121:491-498.
16. Reuben JM, Tanner CE, Protection against experimental echinococcosis by non-specifically stimulated peritoneal cells. Parasite Immunol 1983;5:61-66.
17. Bresson-Hadni S, Petitjean O, Monnot-Jacquard B, Heyd B, Kantelip B, Deschaseaux M, Racadot E, Vuitton DA. Cellular localisations of interleukin-1b, interleukin-6 and tumor necrosis factor-α mRNA in parasitic granulomatous disease of the liver, alveolar echinococcosis. Eur Cytokine Netw 1994;5:461-468.
18. Gallin JI, Farber JM, Holland SM, Nutman TB. Interferon-gamma in the management of infectious diseases. Ann Intern Med 1995;3:216-224.
19. Romani L, Pucetti P, Bistoni F. Interleukin-12 in infectious diseases. Clin Microbiol Rev 1997;4:611-636.
20. Liance M, Ricard-Blum S, Emery I, Houin R, Vuitton DA. Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis. Parasite 1998;5:231-237.
21. Jenne L, Kilwinski J, Radloff P, Scheffold W, Kern P. Clinical efficiency and immunological alterations caused by interferon gamma therapy for alveolar echinococcosis. Clin Infect Dis 1998;26:492-494.
22. Emery I, Leclerc C, Sengphommachanh K, Vuitton DA, Liance M. In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasite Immunol 1998;20:81-91.
23. Herberman R. Effect of alpha-interferons on immune function. Semin Oncol 1997;24:S9-78-S9-80.
24. Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol 1995;15:121-129.
25. Samuel CE. Antiviral actions of interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 1991;183:1-11.
26. Nagy P, Kopper L, Gyapay G, Peterfy F, Lapis K. Effects of interferon-alpha (IFN alpha) on various human tumor xenografts. Anticancer Res 1988;3:467-469.
27. Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J, Rollinghoff M, Gresser I, Bogdan C. Type I interferon (IFN alpha/beta) and type 2 nitric oxide synthetase regulate the innate response to a protozoan parasite. Immunity 1998;1:77-87.
28. Eissa MM, Baddour NM. Parasitological, pathological and functional studies on the effects of IFN alpha 2b in murine hepatic schistosomiasis. Southeast Asian J Trop Med Public Health 2000;31(Suppl A):1-7.
29. Vigario AM, Belnoue E, Cumano A, Marussig M, Miltgen F, Landau I, Mazier D, Gresser I, Rénia L. Inhibition of Plasmodium yoelii blood-stage malaria by interferon alpha through the inhibition of its target cell, the reticulocyte. Blood 2001;97:3966-3971.
30. Liance M, Vuitton DA, Gueret-Stocker S, Carbillet JP, Grimaud JA, Houin R. Experimental alveolar echinococcosis. Suitability of a murine model of intrahepatic infection by Echinococcus multilocularis for immunological studies. Experientia 1984;40:1436-1439.
31. Bresson-Hadni S, Kurtz S, Beurton I, Bartholomot B, Kratzer W, Miguet JP, Vuitton DA, Kern P. Classification of alveolar echinococcosisa bicentric European proposal. J Hepatol 1999;30(suppl 1):166.
32. de Waziěre B, Spehner V, Harraga S, Laplante F, Corallo F, Bloy CH, Dupond JL, Vuitton DA, Seilles E. Alteration in the production of free oxygen radicals and proinflammatory cytokines by peritoneal and alveolar macrophages in old mice and immunomodulatory effect of RU41740 administration. Part 1: Effect of short and repetitive noise stress. Immunopharmacology 1998;39:51-59.
33. Podoprigora G. Phagocytic activity of the mononuclear phagocyte system in gnotobiotic animals under conditions of aging and experimental burn injury. Microecol Ther 1990;20:203-211.
34. Gottstein B, Wunderlin E, Tanner I. Echinococcus multilocularis: parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR, C57BI/6J) or "resistant" (C57BI/10) to secondary alveolar echinococcosis. Clin Exp Immunol 1994;96:245-252.
35. Baron RW, Tanner CE. Echinococcus multilocularis in the mouse: the in vitro protoscolicidal activity of peritoneal macrophages. Int J Parasitol 1977;7:489-495.
36. Alkarmi T, Behbehani K. Echinococcus multilocularis: inhibition of murine neutrophil and macrophage chemotaxis. Exp Parasitol 1989;69:16-22.
37. Rakha NK, Dixon JB, Carter SD, Craig PS, Jenkins P, Folkard S. Echinococcus multilocularis antigens modify accessory cell function of macrophages. Immunology 1991;74:652-656.
38. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin-10. J Exp Med 1991;174:1549-1555.
39. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today 1992;13:198-200.
40. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3444-3451.
41. Cousens L, Orange J, Su H, Biron C. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc Natl Acad Sci U S A 1997;121:634-639.
42. Gessner A, Moskophidis D, Lehmann-Grube F. Enumeration of single IFN-gamma-producing cells in mice during viral and bacterial infection. J Immunol 1989;142:1293-1298.
43. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001;14:461-470.
44. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A. DCs induce CD40-independent immunoglobulin class switching through Blys and APRIL. Nature Immunol 2002;3:822-829.
45. Rau ME, Tanner CE. BCG suppresses growth and metastasis of hydatid infections. Nature 1975;2:318-319.
46. Guerret S, Desmouliere A, Chossegros P, Costa AM, Badid C, Trepo C, Grimaud JA, Chevallier M. Long-term administration of interferon-alpha in non-responder patients with chronic hepatitis C: follow-up of liver fibrosis over 5 years. J Viral Hepatol 1999;6:125-133.
47. Guerret S, Vuitton DA, Liance M, Pater C, Carbillet JP. Echinococcus multilocularis: relationship between susceptibility/resistance of experimental mice and liver fibrogenesis. Parasitol Res 1998;84:657-667.